CRIG awards 9 ‘partnership grants’ to stimulate the interaction between the lab and the clinic
This year, CRIG launched a brand new initiative, namely ‘partnership grants’ for duos – consisting of a fundamental/translational researcher & a health care professional – to initiate innovative cancer research projects at CRIG’s partner institution UGent, UZ Gent and VIB-UGent.
The main purpose of these partnership grants is to stimulate the interaction between the lab and the clinic, and to cross-fertilize fundamental/translational and clinical research. Seed funding (max 40 000 EUR) is provided to create leverage by stimulating and increasing the success rate of future larger project applications, and to maximize chances to build further on the project (e.g. fruitful and durable collaborations that bridge the gap between fundamental research and the clinic, concrete benefit for the patient, increased output, valorization potential, …).
We are proud to announce that within this 1st call, no less than 9 partnership grants (duos) were granted! Six of these projects are awarded in the category ‘general cancer research’ category, and an additional three projects are awarded in the category ‘psychosocial/nursing cancer research’ (evaluated separately from each other). The funding is provided by CRIG, with co-funding from ‘Kankerfonds’ (UZ Gent Kankercentrum) and limited co-funding from vzw Kinderkankerfonds (in the context of its ongoing partnership with CRIG).
Awarded projects in the ‘general cancer research’ category
- Prof. Olivier De Wever & Prof. Gwen Sys – “STS-COPE: Soft Tissue Sarcoma CubOids to guide Precision mEdicine” (39 810 EUR)
- Prof. Katleen De Preter & Prof. Hans Van Vlierberghe – “In-time detection of tumor recurrence in patients with advanced stage hepatocellular carcinoma” (39 900 EUR)
- Prof. Panagiotis Ntziachristos & Prof. Tessa Kerre – “Characterizing and targeting aberrant splicing regulation in pediatric and adult acute leukemia” (40 000 EUR)
- Prof. Jimmy Van den Eynden & Dr. Isabelle Hoorens – “Clonal and tumoural spatial interdependency as unexplored therapeutic opportunities in squamous cell skin cancer” (40 000 EUR)
- Prof. Robrecht Raedt & Dr. Giorgio Hallaert – “Coordinated Undermining of Survival Pathways (CUSP) in glioblastoma” (37 128 EUR)
- Prof. Karolien De Bosscher & Prof. Fritz Offner – “The mineralocorticoid receptor as a novel biomarker and potential therapeutic target against multiple myeloma” (28 500 EUR)
Awarded projects in the ‘psychosocial/nursing cancer research’ category
- Prof. Ann Van Hecke & Dr. Eva Pape – “Young cancer survivors with treatment induced menopause: an exploration of the experiences, needs and perspectives of patients, partners and healthcare professionals” (37 600 EUR)
- Prof. Elke Rammant & Prof. Karen Geboes – “Research priorities for psychosocial oncology and survivorship: A James Lind Alliance Priority Setting Partnership” (26 857 EUR)
- Prof. Kenneth Chambaere & Prof. Sara Debulpaep – “International pediatric palliative sedation practice and physician opinions” (34 500 EUR)
Congratulations to all duos, and we wish them all the best with their exciting partnership projects!
(Upper panel, duos from left to right: Prof. Olivier De Wever & Prof. Gwen Sys; Prof. Hans Van Vlierberghe & Prof. Katleen De Preter; Prof. Panagiotis Ntziachristos & Prof. Tessa Kerre.
Middle panel: Prof. Jimmy Van den Eynden & Dr. Isabelle Hoorens; Prof. Robrecht Raedt & Dr. Giorgio Hallaert; Prof. Fritz Offner & Prof. Karolien De Bosscher.
Lower panel: Prof. Ann Van Hecke & Dr. Eva Pape; Prof. Karen Geboes & Prof. Elke Rammant; Prof. Prof. Sara Debulpaep & Prof. Kenneth Chambaere.)